Low vitamin D status throughout life results in an inflammatory prone status but does not alter bone mineral or strength in healthy 3-month-old CD-1 male mice

Molecular Nutrition and Food Research

Volumn 58, Issue 7, 2014, Pages 1491-1501

  Jahani, Raha ^a   Fielding, Kristina A ^a   Chen, Jianmin ^a   Villa, Christopher R ^a   Castelli, Laura M ^b   Ward, Wendy E ^a,b   Comelli, Elena M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b BROCK UNIVERSITY   (Canada)

Author keywords

Bone strength; Gut microbiota; Intestine; Nutritional programming; Vitamin D

Indexed keywords

CALCITRIOL RECEPTOR; LIPOPOLYSACCHARIDE; VITAMIN D;

ANIMAL; BLOOD; BONE DENSITY; DRUG EFFECTS; FEMALE; GENETICS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTESTINE; LACTATION; MALE; METABOLISM; MICROFLORA; MOUSE; NUTRITIONAL STATUS; PREGNANCY; VITAMIN D DEFICIENCY; WEANING;

ANIMALS; BONE DENSITY; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTESTINES; LACTATION; LIPOPOLYSACCHARIDES; MALE; MICE; MICROBIOTA; NUTRITIONAL STATUS; PREGNANCY; RECEPTORS, CALCITRIOL; VITAMIN D; VITAMIN D DEFICIENCY; WEANING;

EID: 84903524119     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300928     Document Type: Article

References (57)

1. Mellanby, E., Nutrition Classics. The Lancet 1:407-12, 1919. An experimental investigation of rickets. Edward Mellanby. Nutr. Rev. 1976, 34, 338-340.
2. Philip, J., Not all about bones: the non classical role of vitamin D in public health. Perspect. Public Health 2012, 132, 6; discussion 6.
3. Javaid, M. K., Crozier, S. R., Harvey, N. C., Gale, C. R. et al., Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet 2006, 367, 36-43.
4. Viljakainen, H. T., Korhonen, T., Hytinantti, T., Laitinen, E. K. et al., Maternal vitamin D status affects bone growth in early childhood-a prospective cohort study. Osteoporos. Int. 2011, 22, 883-891.
5. Rochat, M. K., Ege, M. J., Plabst, D., Steinle, J. et al., Maternal vitamin D intake during pregnancy increases gene expression of ILT3 and ILT4 in cord blood. Clin. Exp. Allergy 2010, 40, 786-794.
6. Chi, A., Wildfire, J., McLoughlin, R., Wood, R. A. et al., Umbilical cord plasma 25-hydroxyvitamin D concentration and immune function at birth: the Urban Environment and Childhood Asthma study. Clin. Exp. Allergy 2011, 41, 842-850.
7. Fernandes de Abreu, D. A., Ibrahim, E. C., Boucraut, J., Khrestchatisky, M. et al., Severity of experimental autoimmune encephalomyelitis is unexpectedly reduced in mice born to vitamin D-deficient mothers. J. Steroid. Biochem. Mol. Biol. 2010, 121, 250-253.
8. Yu, S., Cantorna, M. T., Epigenetic reduction in invariant NKT cells following in utero vitamin D deficiency in mice. J. Immunol. 2011, 186, 1384-1390.
9. Perez-Ferre, N., Torrejon, M. J., Fuentes, M., Fernandez, M. D. et al., Association of low serum 25-Hydroxyvitamin D levels in pregnancy with glucose homeostasis and obstetric and newborn outcomes. Endocrine Pract. 2012, 18, 1-18.
10. Sorensen, I. M., Joner, G., Jenum, P. A., Eskild, A. et al., Maternal serum levels of 25-hydroxy-vitamin D during pregnancy and risk of type 1 diabetes in the offspring. Diabetes 2012, 61, 175-178.
11. Zittermann, A., Dembinski, J., Stehle, P., Low vitamin D status is associated with low cord blood levels of the immunosuppressive cytokine interleukin-10. Pediatr. Allergy Immunol. 2004, 15, 242-246.
12. Crozier, S. R., Harvey, N. C., Inskip, H. M., Godfrey, K. M. et al., Maternal vitamin D status in pregnancy is associated with adiposity in the offspring: findings from the Southampton Women's Survey. Am. J. Clin. Nutr. 2012, 96, 57-63.
13. Hossein-nezhad, A., Holick, M. F., Optimize dietary intake of vitamin D: an epigenetic perspective. Curr. Opin. Clin. Nutr. Metab. Care 2012, 15, 567-579.
14. Van Ranst, M., Joossens, M., Joossens, S., Van Steen, K. et al., Crohn's disease and month of birth. Inflamm. Bowel Dis. 2005, 11, 597-599.
15. Mikulecky, M., Cierna, I., Seasonality of births and childhood inflammatory bowel disease. Wien. Klin. Wochenschr. 2005, 117, 554-557.
16. Angelucci, E., Cocco, A., Cesarini, M., Crudeli, A. et al., Monthly and seasonal birth patterns and the occurrence of Crohn's disease. Am J. Gastroenterol. 2009, 104, 1608-1609.
17. Disanto, G., Chaplin, G., Morahan, J. M., Giovannoni, G. et al., Month of birth, vitamin D and risk of immune mediated disease: a case control study. BMC Med. 2012, 10, 69.
18. Sonnenberg, A., Date of birth in the occurrence of inflammatory bowel disease. Inflamm. Bowel Dis. 2009, 15, 206-211.
19. Uitterlinden, A. G., Fang, Y., Van Meurs, J. B., Pols, H. A., Van Leeuwen, J. P., Genetics and biology of vitamin D receptor polymorphisms. Gene 2004, 338, 143-156.
20. Wang, T. T., Tavera-Mendoza, L. E., Laperriere, D., Libby, E. et al., Large-scale in silico and microarray-based identification of direct 1, 25-dihydroxyvitamin D3 target genes. Mol. Endocrinol. 2005, 19, 2685-2695.
21. Bouillon, R., Carmeliet, G., Verlinden, L., van Etten, E. et al., Vitamin D and human health: lessons from vitamin D receptor null mice. Endocrinol. Rev. 2008, 29, 726-776.
22. Kong, J., Zhang, Z., Musch, M. W., Ning, G. et al., Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J. Physiol. Gastrointest. Liver Physiol. 2008, 294, G208-G216.
23. Wu, S., Liao, A. P., Xia, Y., Li, Y. C. et al., Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine. Am J. Pathol. 2010, 177, 686-697.
24. Froicu, M., Weaver, V., Wynn, T. A., McDowell, M. A. et al., A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol. Endocrinol. 2003, 17, 2386-2392.
25. Peterson, C. A., Heffernan, M. E., Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women. J. Inflamm. 2008, 5, 10.
26. Lagishetty, V., Misharin, A. V., Liu, N. Q., Lisse, T. S. et al., Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology 2010, 151, 2423-2432.
27. Sjogren, K., Engdahl, C., Henning, P., Lerner, U. H. et al., The gut microbiota regulates bone mass in mice. J. Bone Miner. Res. 2012, 27, 1357-1367.
28. Zou, W., Bar-Shavit, Z., Dual modulation of osteoclast differentiation by lipopolysaccharide. J. Bone Miner. Res. 2002, 17, 1211-1218.
29. Quraishi, S. A., Litonjua, A. A., Moromizato, T., Gibbons, F. K. et al., Association between prehospital vitamin D status and hospital-acquired bloodstream infections. Am J. Clin. Nutr. 2013, 98, 952-959.
30. Canadian Council in Animal Care, Guide to the care and use of experimental animals. 1993, 1-212.
31. Fleet, J. C., Gliniak, C., Zhang, Z., Xue, Y. et al., Serum metabolite profiles and target tissue gene expression define the effect of cholecalciferol intake on calcium metabolism in rats and mice. J. Nutr. 2008, 138, 1114-1120.
32. Allred, D. C., Harvey, J. M., Berardo, M., Clark, G. M., Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod. Pathol. 1998, 11, 155-168.
33. Singh, N., Arioli, S., Wang, A., Villa, C. R. et al., Impact of Bifidobacterium bifidum MIMBb75 on mouse intestinal microorganisms. FEMS Microbiol. Ecol. 2013, 85, 369-375.
34. Pollard, K. S., Van der Laan, M. J., Choice of null distribution in resampling based multiple testing. J. Stat. Plan. Inference 2004, 125, 85-101.
35. Mi, H., Muruganujan, A., Casagrande, J. T., Thomas, P. D., Large-scale gene function analysis with the PANTHER classification system. Nat. Protoc. 2013, 8, 1551-1566.
36. Kaludjerovic, J., Ward, W. E., Neonatal exposure to daidzein, genistein, or the combination modulates bone development in female CD-1 mice. J. Nutr. 2009, 139, 467-473.
37. Garg, M., Lubel, J. S., Sparrow, M. P., Holt, S. G., Gibson, P. R., Review article: vitamin D and inflammatory bowel disease-established concepts and future directions. Aliment. Pharmacol. Ther. 2012, 36, 324-344.
38. Sung, C. C., Liao, M. T., Lu, K. C., Wu, C. C., Role of vitamin D in insulin resistance. J. Biomed. Biotechnol. 2012, 634195.
39. Reid, I. R., Bolland, M. J., Role of vitamin D deficiency in cardiovascular disease. Heart 2012, 98, 609-614.
40. Moromizato, T., Litonjua, A. A., Braun, A. B., Gibbons, F. K. et al., Association of low serum 25-hydroxyvitamin D levels and sepsis in the critically ill. Crit. Care Med. 2014, 42, 97-107.
41. Barengolts, E., Vitamin D and prebiotics may benefit the intestinal microbacteria and improve glucose homeostasis in prediabetes and type 2 diabetes. Endocr. Pract. 2013, 19, 497-510.
42. Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M. et al., Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56, 1761-1772.
43. Drewe, J., Beglinger, C., Fricker, G., Effect of ischemia on intestinal permeability of lipopolysaccharides. Eur. J. Clin. Invest. 2001, 31, 138-144.
44. Ooi, J. H., Li, Y., Rogers, C. J., Cantorna, M. T., Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. J. Nutr. 2013, 143, 1679-1686.
45. Pramanik, R., Asplin, J. R., Lindeman, C., Favus, M. J. et al., Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells. Cell. Immunol. 2004, 232, 137-143.
46. Costello, C. M., Mah, N., Hasler, R., Rosenstiel, P. et al., Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays. PLoS Med. 2005, 2, e199.
47. van der Waaij, L. A., Kroese, F. G., Visser, A., Nelis, G. F. et al., Immunoglobulin coating of faecal bacteria in inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 2004, 16, 669-674.
48. Nadal, I., Santacruz, A., Marcos, A., Warnberg, J. et al., Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents. Int. J. Obesity 2009, 33, 758-767.
49. Rigon, G., Vallone, C., Lucantoni, V., Signore, F., Maternal factors pre- and during delivery contribute to gut microbiota shaping in newborns. Front. Cell. Infect. Microbiol. 2012, 2, 1-4.
50. Khachatryan, Z. A., Ktsoyan, Z. A., Manukyan, G. P., Kelly, D. et al., Predominant role of host genetics in controlling the composition of gut microbiota. PloS One 2008, 3, e3064.
51. Stappenbeck, T. S., Hooper, L. V., Gordon, J. I., Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc. Natl. Acad. Sci. USA 2002, 99, 15451-15455.
52. Bry, L., Falk, P. G., Midtvedt, T., Gordon, J. I., A model of host-microbial interactions in an open mammalian ecosystem. Science 1996, 273, 1380-1383.
53. Gluckman, P. D., Hanson, M. A., Spencer, H. G., Predictive adaptive responses and human evolution. Trends Ecol. Evol. 2005, 20, 527-533.
54. Liu, W., Chen, Y., Golan, M. A., Annunziata, M. L. et al., Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. J. Clin. Investig. 2013, 123, 3983-3996.
55. Lakhdari, O., Tap, J., Beguet-Crespel, F., Le Roux, K. et al., Identification of NF-kappaB modulation capabilities within human intestinal commensal bacteria. J. Biomed. Biotechnol. 2011, 2011, 282356.
56. Ward, W. E., Piekarz, A. V., Fonseca, D., Bone mass, bone strength, and their relationship in developing CD-1 mice. Can. J. Biochem. Physiol. 2007, 85, 274-279.
57. Reeves, P. G., Rossow, K. L., Lindlauf, J., Development and testing of the AIN-93 purified diets for rodents: results on growth, kidney calcification and bone mineralization in rats and mice. J. Nutr. 1993, 123, 1923-1931.